Compression Works

09/03/2026

Turn off the faucet.

Built to control the bleed from the field to the hospital.

See it in use. Explore AAJT-S use cases at: compressionworks.com

09/01/2026

The AAJT-S began with a problem that needed a better answer.

While serving in Iraq, emergency physician and special operations veteran Dr. John Croushorn saw firsthand the challenge of controlling severe abdominal and junctional hemorrhage in the field, particularly during evacuation and prolonged transport.

When conventional extremity tourniquets couldn’t reach the source, options were limited. Manual compression could provide temporary control, but maintaining it during movement and continued patient care presented its own challenges.

Those experiences helped drive the development of a stabilized, external solution designed to provide controlled compression where traditional extremity tourniquets cannot.

Today, the AAJT-S gives military, EMS, and hospital providers another point of control in the response to life-threatening hemorrhage.

Born from a battlefield need. Built to close a critical gap in hemorrhage control.

Learn more about the AAJT-S at CompressionWorks.com

08/27/2026

Can we change the outcomes in traumatic cardiac arrest?

Historically, TCA survival rates below 1% have reinforced the belief that resuscitation is often futile. But emerging field data is challenging that narrative.

At EMS World 2026, John Croushorn, MD, FACEP, will examine coordinated prehospital strategies, including hemorrhage control, whole blood resuscitation, high-performance CPR, and externally applied aortic compression, and the growing evidence for what may be possible when these interventions are rapidly integrated.

From lessons learned on the battlefield to actionable strategies for civilian EMS, this is a conversation about moving beyond historical expectations and improving the response to one of trauma care’s most challenging emergencies.

Join us as we challenge what we’ve come to expect from TCA outcomes.



*The AAJT-S is FDA-cleared for specific indications. Case reports, studies, presentations, and protocols shared here may reference uses outside those cleared indications, including traumatic cardiac arrest (TCA). Such references should not be interpreted as FDA-cleared indications for use.

08/25/2026

Prehospital blood is changing what’s possible in trauma care.

This month, NHTSA’s Office of EMS continued its Prehospital Blood Transfusion in Practice series, bringing together experts and EMS leaders to help agencies navigate the science and implementation of prehospital blood programs.

The growing focus on prehospital blood represents important progress in the care of severely bleeding patients.

Bringing blood products closer to the point of injury expands what EMS teams can do before a patient reaches the hospital. Alongside effective hemorrhage control, it’s part of a shared effort to give patients the best possible chance to survive and reach definitive care.

More capability in the field. More opportunities to save lives.

08/18/2026

The extremity tourniquet was already on.
The patient was still bleeding.

Three gunshot wounds had resulted in a transected deep femoral artery and a hemorrhage control problem that required another approach.

See what happened next → https://compressionworks.com/use-cases/military/21yo-male-3xgsw-afghanistan/

A 21-year-old male in Afghanistan with three GSWs, hemorrhagic shock, and a transected left deep femoral artery survived after the AAJT-S was applied to the left inguinal crease — filling the capability gap no limb tourniquet can reach.

08/13/2026

A firsthand clinical perspective.

Dr. Poliakova shares her experience with the AAJT-S in a published case series.

Read more from Dr. Poliakova and access the published case series: https://compressionworks.com/use-cases/hospital/pph-open-label-case-series/



The AAJT-S is FDA-cleared for specific indications. Case reports, studies, and protocols shared here may reference uses outside those cleared indications, including postpartum hemorrhage (PPH). Such references should not be interpreted as FDA-cleared indications for use.

08/11/2026

The binder was on. Transfusion was underway. Pressors were running. The patient was still deteriorating.

Read the full case → https://compressionworks.com/use-cases/hospital/blunt-pelvic-trauma-graz-austria/

A 27-year-old female survived a catastrophic blunt pelvic injury after a 3-story fall when the AAJT-S, applied in under one minute, achieved hemorrhage control where a pelvic binder, massive transfusion, and vasopressors had failed.

08/07/2026

💡 Did you know? The AAJT-S has a complete removal protocol - and it's already at your fingertips.

Safe, effective use doesn't end with application. Our Application & Removal Guide covers every step, including why removal should always be gradual and monitored: premature removal may result in resumed bleeding.

Find the full removal poster and training materials on our website. 👉

https://compressionworks.com/training-protocol/

compressionworks.com

08/06/2026

Ready to move from decision to implementation?
Don't let the paperwork slow you down.

Our Protocol Library is a growing collection of real-world AAJT-S protocols from agencies across the country. See how others have incorporated the AAJT-S into their protocols and use their experience as a starting point for your own.

Already have an AAJT-S protocol in place? Share it with us. Help the next agency spend less time on paperwork and more time moving toward implementation.

compressionworks.com/protocol-library/

08/03/2026

Compression Works will be at MHSRS 2026, August 3–6 in Kissimmee, FL.

Dr. John Croushorn, Co-Founder and CMO, and Nicole Iezzi, VP of Global Sales, will be there. If you're attending, we'd love the opportunity to connect!